| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) |
357 |
324 |
$1.07M |
| J1602 |
Injection, golimumab, 1 mg, for intravenous use |
524 |
392 |
$963K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,691 |
2,649 |
$206K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
1,795 |
1,658 |
$158K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,392 |
2,337 |
$126K |
| 99205 |
Prolong outpt/office vis |
181 |
181 |
$26K |
| J0717 |
Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) |
14 |
12 |
$23K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
216 |
216 |
$23K |
| 99215 |
Prolong outpt/office vis |
139 |
139 |
$15K |
| 96401 |
|
15 |
13 |
$1K |
| 96415 |
|
16 |
12 |
$431.75 |